Amazon.com IncHSBC expects Amazon to benefit from continued cloud computing demand and AI infrastructure investments.
HSBC identified 10 Buy-rated stocks it believes are well positioned ahead of the second-quarter earnings season, citing favorable trends across technology, financial, consumer and industrial sectors. The firm named Amazon, Microsoft, Meta Platforms, Alphabet, AbbVie, Caterpillar, Marriott International, Vertiv, NextPower and Wells Fargo as its preferred earnings-season ideas, reflecting company-specific growth drivers rather than a single sector theme. HSBC expects Amazon to benefit from continued cloud computing demand and AI infrastructure investments, while Microsoft could see further momentum from Azure AI services. The brokerage also pointed to Meta's AI-powered advertising tools, Alphabet's cloud and search businesses, and Vertiv's exposure to expanding data center spending. Outside technology, HSBC said AbbVie's immunology portfolio, Caterpillar's exposure to AI-related power demand, Marriott's asset-light business model and Wells Fargo's improving earnings outlook could support results, and highlighted NextPower's project backlog and expansion efforts as potential growth catalysts.
Amazon.com IncHSBC expects Amazon to benefit from continued cloud computing demand and AI infrastructure investments.
Alphabet Inc Class CHSBC points to Alphabet's cloud and search businesses as key earnings catalysts.
Meta Platforms Inc.HSBC highlights Meta's AI-powered advertising tools as a growth driver for earnings.
Microsoft CorporationHSBC expects Microsoft to benefit from Azure AI services momentum.
Vertiv Holdings CoHSBC points to Vertiv's exposure to expanding data center spending.
Caterpillar IncHSBC cites Caterpillar's exposure to AI-related power demand as a growth driver.
Nextpower Inc.HSBC cites Nextracker's project backlog and expansion efforts as growth catalysts.
Wells Fargo & CompanyHSBC notes Wells Fargo's improving earnings outlook as a support for results.
HSBC Holdings PLC
AbbVie IncHSBC highlights AbbVie's immunology portfolio as a growth catalyst ahead of Q2 earnings.
Marriott International IncHSBC highlights Marriott's asset-light business model as supporting earnings outlook.